+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
From
Cancer Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Therapeutics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Cancer Immunotherapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Immunotherapy Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Digital Marketing Trends in Breast Cancer - Product Thumbnail Image

Digital Marketing Trends in Breast Cancer

  • Report
  • November 2022
  • 34 Pages
  • Global
From
Biotechnology in the US - Market Research Report 2015-2030 - Product Thumbnail Image

Biotechnology in the US - Market Research Report 2015-2030

  • Report
  • March 2025
  • 51 Pages
  • United States
From
From
Multiple Sclerosis: Dynamic Market Forecast to 2026 - Product Thumbnail Image

Multiple Sclerosis: Dynamic Market Forecast to 2026

  • Report
  • November 2018
  • 53 Pages
  • Global
From
Company Snapshots: US Pharmaceuticals - Product Thumbnail Image

Company Snapshots: US Pharmaceuticals

  • Newsletter
  • February 2026
  • 35 Pages
  • United States
From
Industry Snapshots: US Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: US Pharmaceuticals

  • Newsletter
  • February 2026
  • 50 Pages
  • United States
From
Stroke - Pipeline Review, H2 2020 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 773 Pages
  • Global
From
Loading Indicator